House Dust Mite Immunotherapy

house dust mite allergen extract

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for House Dust Mite Immunotherapy, covering 2013-02-07 to 2024-07-19. Get the full timeline:

Most recent: Clinical Trial Update: Dupilumab and House Dust Mite Immunotherapy in Patients With Atopic Dermatitis [NA]